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Results
A total of 186 records were identified using electronic searches, with eight additional records identified through other sources. After removing duplicates, 104 studies were screened, and seven studies were identified that met the inclusion criteria for this review.
Three studies, with a total of 241 participants, met the inclusion criteria and had data that could be included in the review's analysis. No studies reported on the primary outcome, cumulative pain intensity over the first 72 hours following surgery assessed on a 100mm VAS. One study reported no difference in mean pain score during the first, second, and third postoperative 24-hour periods in participants receiving liposomal bupivacaine TAP block compared to no TAP block. Two studies investigating TAP block reported opposing findings concerning cumulative postoperative opioid consumption. One study reported a significant reduction in cumulative opioid consumption over the first 72 hours associated with the use of liposomal bupivacaine TAP block versus bupivacaine hydrochloride TAP block. However, the second study found no difference for that outcome when liposomal bupivacaine TAP block was compared to control (no TAP block). No studies reported on the remaining secondary outcomes: time to first postoperative opioid; percentage not requiring opioids over the initial 72 hours; health economic analysis; patientreported outcome measures, other than pain. The authors sought data regarding adverse events but none were available; however, no withdrawals because of adverse events were reported.
All of the studies included in the review were small and therefore at high risk of bias for sample size. The quality of the evidence was rated very low because of high risk of bias, inconsistency of results and the limited data available.
Future high quality randomised controlled trials with larger sample sizes are required, and should focus on surgeries associated with higher morbidity, severe postoperative pain and delayed hospital discharge. Additionally, the costeffectiveness and side effects profile of liposomal bupivacaine requires evaluation. When sufficient evidence is available, future reviews should analyse data for different types of surgery separately, since uncontrolled pain is more commonly associated with particular procedures such as thoracic, abdominal and joint replacement. Therefore, future pain management strategies might be informed by evidence that is more procedure-specific.
Conclusion
As a result of the lack of high quality evidence, there are insufficient data to support or refute the use of liposomal bupivacaine as a PNB for postoperative pain. Future high quality trials with larger sample sizes are required.
Implications for practice
• The safety and effectiveness of liposomal bupivacaine as a PNB for the management of postoperative pain remains unknown. Consequently, postoperative pain management will continue as per usual practice.
• Postoperative pain management is an ongoing problem for a large proportion of patients who have had surgery, and many require high levels of postoperative support. It is important to identify and evaluate improvements to postoperative pain management, including new approaches to anaesthesia, such as the use of liposomal bupivacaine. Effective pain management can reduce complications and improve patient outcomes after surgery (Rockett et al 2015) .
• The safe administration and monitoring of medicines is a crucial aspect of the nurse's role. It is essential that nursing care combines knowledge and competence in pharmacological pain management alongside nonpharmacological measures, such as providing reassurance and information to reduce patients' anxiety.
• Preoperative prediction of patients who are likely to experience severe acute pain postoperatively as well as identifying patients at risk of chronic pain is becoming part of pre-assessment (Rockett et al 2015) . This provides nurses with the opportunity to optimise the patient's pain management plan before surgery, including analgesia and strategies to cope with pain.
